Logo LENV 4 mg (Lenvima 4 mg)
Generic Name: lenvatinib
Pill imprint Logo LENV 4 mg has been identified as Lenvima 4 mg.
Lenvima is used in the treatment of thyroid cancer; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Lenvima 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Lenvima (lenvatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.